ETS1 and breast cancer: The ETS1 overexpression promotes malignancy through HGF/Met-mediated motility, which allows breast cancer cells to bypass the requirement of promigratory signals supplied by the environment (such as fibronectin) for invading (Furlan et al, 2008).